0.43
+0.0599(+16.16%)
Currency In USD
| Previous Close | 0.37 |
| Open | 0.43 |
| Day High | 0.43 |
| Day Low | 0.43 |
| 52-Week High | 14.28 |
| 52-Week Low | 0.25 |
| Volume | 6 |
| Average Volume | 97,131 |
| Market Cap | 830,153 |
| PE | -0.03 |
| EPS | -14.76 |
| Moving Average 50 Days | 0.9 |
| Moving Average 200 Days | 2.7 |
| Change | 0.06 |
If you invested $1000 in Protagenic Therapeutics, Inc. (PTIX) since IPO date, it would be worth $3.4 as of February 21, 2026 at a share price of $0.431. Whereas If you bought $1000 worth of Protagenic Therapeutics, Inc. (PTIX) shares 3 years ago, it would be worth $14.17 as of February 21, 2026 at a share price of $0.431.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Protagenic Therapeutics Announces Grant of new patent in Japan for its Modified Stilbenoid Program Drug Candidates
GlobeNewswire Inc.
Jul 30, 2025 12:30 PM GMT
NEW YORK and SANTA BARBARA, Calif., July 30, 2025 (GLOBE NEWSWIRE) -- Protagenic Therapeutics, Inc. (Nasdaq: PTIX) (the “Company”) today announces that on July 18, 2025, the Japanese Patent Office granted Patent JP 7714571B, a patent which runs until